» Articles » PMID: 25899778

Novel Microcatheter-based Intracarotid Delivery Approach for MCAO/R Mice

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2015 Apr 23
PMID 25899778
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The intra-arterial (IA) model by microcatheter administration was an effective way to deliver drugs or cells to the brain. All of these models were carried out introduced in rat rather than mice for the difficult and technically challenging due to their small caliber. In 2014, Alejandro Santillan first introduced this model in mice and we found that most of the operational steps were similar with the middle cerebral artery occlusion and reperfusion (MCAO/R) model. We attempted to combine these two techniques into a single model in mice and discovered that this technique was indeed possible. In our work, 12C57Bl/6J male mice were carried on middle cerebral artery occlusion for 60min and then the intra-arterial microcatheter was placed into the internal carotid artery (ICA) from the external carotid artery (ECA). GFP-Luc-Pro labeled mNSCs were infused through the microcatheter and then the blood flow perfusion was reestablished subsequently. The results showed that all 12 mice were carried on successfully the model of middle cerebral artery occlusion, and the placement of the microcatheter and the mNSCs perfusion were completed smoothly without exception. Which means that it is logical to combine the two models into one in order to facilitate studying of stroke. Meanwhile, during the dissection, we found the variation of occipital artery (OA) was noticeable and we classified first time this variation into four categories to attempt to protect the OA.

Citing Articles

Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery.

Zhang S, Peng B, Chen Z, Yu J, Deng G, Bao Y Bioact Mater. 2022; 16:57-65.

PMID: 35386312 PMC: 8958421. DOI: 10.1016/j.bioactmat.2022.02.033.


Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke.

Wang Y, Wang Y, Li S, Cui Y, Liang X, Shan J J Nanobiotechnology. 2021; 19(1):331.

PMID: 34674712 PMC: 8529766. DOI: 10.1186/s12951-021-01067-0.


Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles.

Deng G, Ma C, Zhao H, Zhang S, Liu J, Liu F Theranostics. 2019; 9(23):6991-7002.

PMID: 31660082 PMC: 6815966. DOI: 10.7150/thno.35791.


Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells.

Ma J, Zhang S, Liu J, Liu F, Du F, Li M Small. 2019; 15(35):e1902011.

PMID: 31290245 PMC: 11089900. DOI: 10.1002/smll.201902011.


Daphnetin Protects against Cerebral Ischemia/Reperfusion Injury in Mice via Inhibition of TLR4/NF-B Signaling Pathway.

Liu J, Chen Q, Jian Z, Xiong X, Shao L, Jin T Biomed Res Int. 2017; 2016:2816056.

PMID: 28119924 PMC: 5227117. DOI: 10.1155/2016/2816056.